ArticleFrontiers in oncology2022

Identification of a novel gene signature of lung adenocarcinoma based on epidermal growth factor receptor-tyrosine kinase inhibitor resistance.

E Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.